nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—Conjugated Estrogens—COMT—conduct disorder	0.0391	0.686	CrCbGaD
Estradiol—Testosterone—MAOA—conduct disorder	0.0179	0.314	CrCbGaD
Estradiol—SLC22A2—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00869	0.00922	CbGpPWpGaD
Estradiol—GPER1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00846	0.00898	CbGpPWpGaD
Estradiol—ESR2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00828	0.00878	CbGpPWpGaD
Estradiol—ABCC10—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00813	0.00863	CbGpPWpGaD
Estradiol—SLC22A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0081	0.00859	CbGpPWpGaD
Estradiol—CYP1A1—Melatonin metabolism and effects—MAOA—conduct disorder	0.00799	0.00848	CbGpPWpGaD
Estradiol—CYP1A1—Oxidative Stress—MAOA—conduct disorder	0.00778	0.00825	CbGpPWpGaD
Estradiol—ESRRA—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00775	0.00822	CbGpPWpGaD
Estradiol—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.00752	0.00797	CbGpPWpGaD
Estradiol—SLCO4A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00736	0.0078	CbGpPWpGaD
Estradiol—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.00654	0.00694	CbGpPWpGaD
Estradiol—GPER1—GPCR ligand binding—HTR2A—conduct disorder	0.00645	0.00684	CbGpPWpGaD
Estradiol—ESR2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00623	0.0066	CbGpPWpGaD
Estradiol—SLCO1C1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00616	0.00654	CbGpPWpGaD
Estradiol—CYP1B1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00588	0.00624	CbGpPWpGaD
Estradiol—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0058	0.00615	CbGpPWpGaD
Estradiol—UGT1A1—Phase II conjugation—COMT—conduct disorder	0.00577	0.00612	CbGpPWpGaD
Estradiol—ESRRA—PPARA activates gene expression—EP300—conduct disorder	0.00559	0.00593	CbGpPWpGaD
Estradiol—GPER1—GPCR downstream signaling—DRD4—conduct disorder	0.00558	0.00592	CbGpPWpGaD
Estradiol—ESR2—Validated nuclear estrogen receptor alpha network—EP300—conduct disorder	0.00549	0.00582	CbGpPWpGaD
Estradiol—ESRRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00547	0.0058	CbGpPWpGaD
Estradiol—AR—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00542	0.00575	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—CGA—conduct disorder	0.00535	0.00567	CbGpPWpGaD
Estradiol—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0053	0.00562	CbGpPWpGaD
Estradiol—SLC22A2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00522	0.00553	CbGpPWpGaD
Estradiol—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.0051	0.0054	CbGpPWpGaD
Estradiol—ESR2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00508	0.00538	CbGpPWpGaD
Estradiol—UGT1A1—NRF2 pathway—SLC6A4—conduct disorder	0.00508	0.00538	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—DRD4—conduct disorder	0.00507	0.00538	CbGpPWpGaD
Estradiol—SLC22A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00486	0.00516	CbGpPWpGaD
Estradiol—AR—FOXA1 transcription factor network—EP300—conduct disorder	0.00485	0.00514	CbGpPWpGaD
Estradiol—AR—Notch-mediated HES/HEY network—EP300—conduct disorder	0.0046	0.00488	CbGpPWpGaD
Estradiol—ABCG2—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.00449	0.00476	CbGpPWpGaD
Estradiol—SLCO2B1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00447	0.00474	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—WASF1—conduct disorder	0.00429	0.00454	CbGpPWpGaD
Estradiol—ESRRA—Gene Expression—POLR3A—conduct disorder	0.00423	0.00448	CbGpPWpGaD
Estradiol—AR—Regulation of Androgen receptor activity—EP300—conduct disorder	0.00418	0.00443	CbGpPWpGaD
Estradiol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00416	0.00441	CbGpPWpGaD
Estradiol—AR—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00408	0.00432	CbGpPWpGaD
Estradiol—SLC22A11—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00405	0.0043	CbGpPWpGaD
Estradiol—SLC22A2—Neuronal System—GABRA2—conduct disorder	0.004	0.00424	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00391	0.00415	CbGpPWpGaD
Estradiol—CYP1B1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00388	0.00411	CbGpPWpGaD
Estradiol—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00388	0.00411	CbGpPWpGaD
Estradiol—ESR1—FOXM1 transcription factor network—EP300—conduct disorder	0.00388	0.00411	CbGpPWpGaD
Estradiol—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00383	0.00407	CbGpPWpGaD
Estradiol—NR1I2—Gene Expression—POLR3A—conduct disorder	0.00382	0.00406	CbGpPWpGaD
Estradiol—ESRRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00377	0.004	CbGpPWpGaD
Estradiol—ESR1—FOXA1 transcription factor network—EP300—conduct disorder	0.00373	0.00396	CbGpPWpGaD
Estradiol—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.00373	0.00395	CbGpPWpGaD
Estradiol—GPER1—GPCR downstream signaling—HTR2A—conduct disorder	0.00364	0.00386	CbGpPWpGaD
Estradiol—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00362	0.00384	CbGpPWpGaD
Estradiol—ESR1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.0036	0.00382	CbGpPWpGaD
Estradiol—SLCO1B3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00349	0.0037	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—CGA—conduct disorder	0.00345	0.00366	CbGpPWpGaD
Estradiol—SLC22A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00343	0.00363	CbGpPWpGaD
Estradiol—UGT1A1—Biological oxidations—COMT—conduct disorder	0.00337	0.00358	CbGpPWpGaD
Estradiol—UGT1A1—Biological oxidations—MAOA—conduct disorder	0.00335	0.00355	CbGpPWpGaD
Estradiol—UGT1A1—Metapathway biotransformation—COMT—conduct disorder	0.00333	0.00353	CbGpPWpGaD
Estradiol—AR—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00332	0.00352	CbGpPWpGaD
Estradiol—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00332	0.00352	CbGpPWpGaD
Estradiol—GPER1—Signaling by GPCR—HTR2A—conduct disorder	0.00331	0.00351	CbGpPWpGaD
Estradiol—CYP1B1—Biological oxidations—COMT—conduct disorder	0.00315	0.00334	CbGpPWpGaD
Estradiol—CYP1B1—Biological oxidations—MAOA—conduct disorder	0.00312	0.00331	CbGpPWpGaD
Estradiol—CYP1B1—Metapathway biotransformation—COMT—conduct disorder	0.0031	0.00329	CbGpPWpGaD
Estradiol—SLC22A8—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00309	0.00328	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00308	0.00326	CbGpPWpGaD
Estradiol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—conduct disorder	0.003	0.00319	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—DRD4—conduct disorder	0.00299	0.00318	CbGpPWpGaD
Estradiol—AR—Regulation of nuclear SMAD2/3 signaling—EP300—conduct disorder	0.00297	0.00315	CbGpPWpGaD
Estradiol—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00296	0.00314	CbGpPWpGaD
Estradiol—ESR1—ATF-2 transcription factor network—EP300—conduct disorder	0.00295	0.00313	CbGpPWpGaD
Estradiol—CYP3A7—Biological oxidations—COMT—conduct disorder	0.00284	0.00301	CbGpPWpGaD
Estradiol—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.00282	0.00299	CbGpPWpGaD
Estradiol—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.0028	0.00297	CbGpPWpGaD
Estradiol—ESR1—Validated nuclear estrogen receptor alpha network—EP300—conduct disorder	0.00277	0.00293	CbGpPWpGaD
Estradiol—AR—Androgen receptor signaling pathway—EP300—conduct disorder	0.00276	0.00293	CbGpPWpGaD
Estradiol—SLCO1A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00274	0.00291	CbGpPWpGaD
Estradiol—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0027	0.00287	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—POLR3A—conduct disorder	0.00269	0.00285	CbGpPWpGaD
Estradiol—ESR2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00269	0.00285	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00268	0.00284	CbGpPWpGaD
Estradiol—ABCG2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00264	0.0028	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00263	0.00279	CbGpPWpGaD
Estradiol—ESR1—AP-1 transcription factor network—EP300—conduct disorder	0.00258	0.00273	CbGpPWpGaD
Estradiol—SLC22A2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00251	0.00266	CbGpPWpGaD
Estradiol—SLC22A2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00249	0.00264	CbGpPWpGaD
Estradiol—AOX1—Metabolism—CGA—conduct disorder	0.00239	0.00254	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00239	0.00253	CbGpPWpGaD
Estradiol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00239	0.00253	CbGpPWpGaD
Estradiol—SLCO1B1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00235	0.00249	CbGpPWpGaD
Estradiol—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00234	0.00248	CbGpPWpGaD
Estradiol—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00232	0.00246	CbGpPWpGaD
Estradiol—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00231	0.00245	CbGpPWpGaD
Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—conduct disorder	0.00229	0.00243	CbGpPWpGaD
Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00229	0.00243	CbGpPWpGaD
Estradiol—ABCG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00217	0.0023	CbGpPWpGaD
Estradiol—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00215	0.00228	CbGpPWpGaD
Estradiol—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00211	0.00224	CbGpPWpGaD
Estradiol—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00205	0.00218	CbGpPWpGaD
Estradiol—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00204	0.00216	CbGpPWpGaD
Estradiol—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00202	0.00215	CbGpPWpGaD
Estradiol—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.002	0.00212	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—HTR2A—conduct disorder	0.00195	0.00207	CbGpPWpGaD
Estradiol—CYP1A1—Biological oxidations—COMT—conduct disorder	0.00194	0.00205	CbGpPWpGaD
Estradiol—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.00192	0.00204	CbGpPWpGaD
Estradiol—SLC22A2—Neuronal System—COMT—conduct disorder	0.00192	0.00204	CbGpPWpGaD
Estradiol—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.00191	0.00203	CbGpPWpGaD
Estradiol—SLC22A2—Neuronal System—MAOA—conduct disorder	0.00191	0.00203	CbGpPWpGaD
Estradiol—AR—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00181	0.00192	CbGpPWpGaD
Estradiol—SLC22A1—Neuronal System—COMT—conduct disorder	0.00179	0.0019	CbGpPWpGaD
Estradiol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00178	0.00189	CbGpPWpGaD
Estradiol—SLC22A1—Neuronal System—MAOA—conduct disorder	0.00178	0.00189	CbGpPWpGaD
Estradiol—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00178	0.00188	CbGpPWpGaD
Estradiol—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00176	0.00187	CbGpPWpGaD
Estradiol—AR—Gene Expression—POLR3A—conduct disorder	0.00176	0.00187	CbGpPWpGaD
Estradiol—AR—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00176	0.00187	CbGpPWpGaD
Estradiol—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00175	0.00186	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—CGA—conduct disorder	0.00174	0.00185	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—CGA—conduct disorder	0.00171	0.00181	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00165	0.00175	CbGpPWpGaD
Estradiol—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00159	0.00168	CbGpPWpGaD
Estradiol—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.00157	0.00167	CbGpPWpGaD
Estradiol—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00156	0.00166	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—COMT—conduct disorder	0.00156	0.00165	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—MAOA—conduct disorder	0.00155	0.00164	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00152	0.00161	CbGpPWpGaD
Estradiol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00152	0.00161	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00151	0.0016	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0015	0.00159	CbGpPWpGaD
Estradiol—ESRRA—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.0015	0.00159	CbGpPWpGaD
Estradiol—AR—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.0015	0.00159	CbGpPWpGaD
Estradiol—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00145	0.00153	CbGpPWpGaD
Estradiol—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00144	0.00152	CbGpPWpGaD
Estradiol—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00143	0.00151	CbGpPWpGaD
Estradiol—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00143	0.00151	CbGpPWpGaD
Estradiol—ESR1—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00139	0.00148	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—CGA—conduct disorder	0.00137	0.00145	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—POLR3A—conduct disorder	0.00136	0.00144	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00135	0.00143	CbGpPWpGaD
Estradiol—ALB—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00134	0.00142	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—CGA—conduct disorder	0.00128	0.00136	CbGpPWpGaD
Estradiol—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00124	0.00131	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00123	0.0013	CbGpPWpGaD
Estradiol—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00123	0.0013	CbGpPWpGaD
Estradiol—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00122	0.00129	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—CGA—conduct disorder	0.00119	0.00126	CbGpPWpGaD
Estradiol—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	0.00119	0.00126	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00117	0.00125	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—CGA—conduct disorder	0.00117	0.00124	CbGpPWpGaD
Estradiol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00116	0.00123	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00115	0.00122	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—CGA—conduct disorder	0.00108	0.00115	CbGpPWpGaD
Estradiol—AOX1—Metabolism—COMT—conduct disorder	0.00108	0.00115	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—CGA—conduct disorder	0.00107	0.00114	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—CGA—conduct disorder	0.00107	0.00114	CbGpPWpGaD
Estradiol—AOX1—Metabolism—MAOA—conduct disorder	0.00107	0.00114	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00105	0.00111	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—EP300—conduct disorder	0.00104	0.0011	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—CGA—conduct disorder	0.001	0.00106	CbGpPWpGaD
Estradiol—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000954	0.00101	CbGpPWpGaD
Estradiol—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000947	0.001	CbGpPWpGaD
Estradiol—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00094	0.000997	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CGA—conduct disorder	0.000927	0.000983	CbGpPWpGaD
Estradiol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.000801	0.00085	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—COMT—conduct disorder	0.000787	0.000835	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—MAOA—conduct disorder	0.000781	0.000829	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CGA—conduct disorder	0.000777	0.000824	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—COMT—conduct disorder	0.000772	0.000819	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—MAOA—conduct disorder	0.000767	0.000813	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000758	0.000804	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—WASF1—conduct disorder	0.000743	0.000788	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CGA—conduct disorder	0.000734	0.000779	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CGA—conduct disorder	0.000673	0.000714	CbGpPWpGaD
Estradiol—ALB—Metabolism—CGA—conduct disorder	0.000669	0.00071	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—EP300—conduct disorder	0.000669	0.000709	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—COMT—conduct disorder	0.000618	0.000656	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—MAOA—conduct disorder	0.000614	0.000651	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00061	0.000647	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CGA—conduct disorder	0.000601	0.000637	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000595	0.000631	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CGA—conduct disorder	0.000586	0.000622	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—COMT—conduct disorder	0.000577	0.000612	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—MAOA—conduct disorder	0.000573	0.000608	CbGpPWpGaD
Estradiol—AOX1—Disease—EP300—conduct disorder	0.000553	0.000587	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CGA—conduct disorder	0.000548	0.000581	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—COMT—conduct disorder	0.000538	0.000571	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—MAOA—conduct disorder	0.000534	0.000567	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—COMT—conduct disorder	0.000529	0.000561	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—MAOA—conduct disorder	0.000525	0.000557	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—DRD4—conduct disorder	0.000519	0.00055	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000518	0.000549	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000509	0.00054	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—COMT—conduct disorder	0.00049	0.000519	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—MAOA—conduct disorder	0.000486	0.000516	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—COMT—conduct disorder	0.000485	0.000515	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—COMT—conduct disorder	0.000484	0.000514	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—MAOA—conduct disorder	0.000482	0.000511	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—MAOA—conduct disorder	0.000481	0.00051	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CGA—conduct disorder	0.000468	0.000496	CbGpPWpGaD
Estradiol—AOX1—Metabolism—EP300—conduct disorder	0.000463	0.000491	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—COMT—conduct disorder	0.000452	0.000479	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—MAOA—conduct disorder	0.000448	0.000476	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CGA—conduct disorder	0.000361	0.000383	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—COMT—conduct disorder	0.000351	0.000372	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—MAOA—conduct disorder	0.000348	0.000369	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—HTR2A—conduct disorder	0.000339	0.000359	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—EP300—conduct disorder	0.000337	0.000358	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—COMT—conduct disorder	0.000331	0.000351	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—EP300—conduct disorder	0.000331	0.000351	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—MAOA—conduct disorder	0.000329	0.000349	CbGpPWpGaD
Estradiol—ALB—Hemostasis—EP300—conduct disorder	0.00032	0.000339	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000319	0.000338	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—COMT—conduct disorder	0.000304	0.000322	CbGpPWpGaD
Estradiol—ALB—Metabolism—COMT—conduct disorder	0.000302	0.00032	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—MAOA—conduct disorder	0.000302	0.00032	CbGpPWpGaD
Estradiol—ALB—Metabolism—MAOA—conduct disorder	0.0003	0.000318	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000293	0.00031	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000291	0.000308	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—COMT—conduct disorder	0.000271	0.000288	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—MAOA—conduct disorder	0.000269	0.000286	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—EP300—conduct disorder	0.000265	0.000281	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—COMT—conduct disorder	0.000265	0.000281	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—MAOA—conduct disorder	0.000263	0.000279	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000261	0.000277	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—EP300—conduct disorder	0.000247	0.000262	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—COMT—conduct disorder	0.000247	0.000262	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—MAOA—conduct disorder	0.000246	0.00026	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000238	0.000252	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—EP300—conduct disorder	0.000231	0.000245	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—EP300—conduct disorder	0.000227	0.00024	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—COMT—conduct disorder	0.000211	0.000224	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—EP300—conduct disorder	0.00021	0.000223	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—MAOA—conduct disorder	0.00021	0.000222	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—EP300—conduct disorder	0.000208	0.000221	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—EP300—conduct disorder	0.000208	0.00022	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000203	0.000216	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—EP300—conduct disorder	0.000194	0.000205	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—EP300—conduct disorder	0.000179	0.00019	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—COMT—conduct disorder	0.000163	0.000173	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—MAOA—conduct disorder	0.000162	0.000172	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—EP300—conduct disorder	0.00015	0.00016	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—EP300—conduct disorder	0.000142	0.000151	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—EP300—conduct disorder	0.00013	0.000138	CbGpPWpGaD
Estradiol—ALB—Metabolism—EP300—conduct disorder	0.00013	0.000137	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—EP300—conduct disorder	0.000116	0.000123	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—EP300—conduct disorder	0.000114	0.00012	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—EP300—conduct disorder	0.000106	0.000112	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—EP300—conduct disorder	9.06e-05	9.61e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—EP300—conduct disorder	6.99e-05	7.42e-05	CbGpPWpGaD
